US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
NVDA
$233.95
▲+0.00%
JNJ
$256.03
▲+0.00%
SNDK
$1,719.99
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
NVDA
$233.95
▲+0.00%
JNJ
$256.03
▲+0.00%
SNDK
$1,719.99
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Jaguar Health, Inc. - Common Stock
(NQ:
JAGX
)
3.660
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jaguar Health, Inc. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients
November 19, 2021
Crofelemer is a novel, oral plant-based non-opioid antidiarrheal medication SAN FRANCISCO, CA / ACCESSWIRE / November 19, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced topline results of the...
From
Jaguar Health, Inc.
Via
AccessWire
Looking Into Jaguar Health's Return On Capital Employed
↗
November 17, 2021
According to data from Benzinga Pro, during Q3, Jaguar Health's (NASDAQ:JAGX) reported sales totaled $630.00 thousand. Despite a 17.71% increase in earnings, the company posted a...
Via
Benzinga
Jaguar Health: Q3 Earnings Insights
↗
November 17, 2021
Jaguar Health (NASDAQ:JAGX) reported its Q3 earnings results on Wednesday, November 17, 2021 at 08:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Jaguar Health Reports 2021 Third Quarter Financial Results
November 17, 2021
Mytesi® prescription volume increased 7.6% in Q3 2021 over Q2 2021 Third quarter 2021 Mytesi net and gross sales were approximately $0.6 million and approximately $3.2 million Company expects to...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Earnings Scheduled For November 17, 2021
↗
November 17, 2021
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion....
Via
Benzinga
Jaguar Health's Earnings Outlook
↗
November 16, 2021
Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Wednesday, 2021-11-17. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Jaguar Health's Italian Subsidiary Napo EU Appoints Massimo Mineo General Manager
November 16, 2021
REMINDER: Jaguar to host investor webcast Wednesday, November 17th at 8:30 a.m. Eastern regarding third quarter 2021 financials & business updates; Click here to register for webcast SAN FRANCISCO, CA...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Investor Webcast Rescheduled for Wednesday, November 17th at 8:30 AM Eastern Time
November 15, 2021
Click here to register for webcast Company plans to file Q3 2021 10-Q on November 17, 2021 SAN FRANCISCO, CA / ACCESSWIRE / November 15, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that...
From
Jaguar Health, Inc.
Via
AccessWire
Earnings Preview: Jaguar Health
↗
November 12, 2021
Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Jaguar Health to Host Investor Webcast Monday, November 15th at 8:30 AM Eastern Time Regarding Q3 2021 Financials & Business Updates
November 10, 2021
Click here to register for webcast Company plans to file Q3 2021 10-Q on November 15, 2021 SAN FRANCISCO, CA / ACCESSWIRE / November 10, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that...
From
Jaguar Health, Inc.
Via
AccessWire
Earnings Scheduled For November 15, 2021
↗
November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to...
Via
Benzinga
Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer
November 08, 2021
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced the appointment by Napo EU S.p.A., the company's Italian subsidiary, of Annabella Amatulli as chief...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing Way for December 2021 Launch
November 02, 2021
Canalevia™-CA1 is the first and only oral plant-based prescription drug candidate for CID in dogs Jaguar kicks off educational awareness contest in honor of International Jaguar Day; Click here to...
From
Jaguar Health, Inc.
Via
AccessWire
The Merger of Dragon SPAC S.p.A. and Napo EU S.p.A. has Closed
November 01, 2021
The combined entity is named Napo EU S.p.A. SAN FRANCISCO, CA / ACCESSWIRE / November 1, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the merger of its Italian subsidiary Napo EU...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 29, 2021
SAN FRANCISCO, CA / ACCESSWIRE / October 29, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that, effective October 25, 2021, the Company granted nonstatutory...
From
Jaguar Health, Inc.
Via
AccessWire
64 Biggest Movers From Yesterday
↗
October 28, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 27, 2021
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 27, 2021
Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
October 27, 2021
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 25, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar...
Via
Benzinga
Italian Government Clears Merger Plan of Dragon SPAC S.p.A. and Jaguar Health's Italian Subsidiary Napo EU S.p.A. for Closing
October 25, 2021
Merger expected to be effective within a week The combined entity will be named Napo EU S.p.A. Merger effects the exclusive license agreement between Jaguar and Napo EU S.p.A. including up-front...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. and Dragon SPAC S.p.A.
October 07, 2021
Dragon SPAC and Jaguar subsidiary Napo EU submit required notification to the Italian government in support of consummating the merger Results accepted for third-party, investigator-initiated Phase 2...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Earnings Perspective: Return On Capital Employed
↗
October 01, 2021
Jaguar Health (NASDAQ:JAGX) brought in sales totaling $385.00 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 32.1%, resulting in a loss...
Via
Benzinga
Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
September 30, 2021
Award celebrates Ms. Conte's 30-year, unrelenting commitment to supporting Indigenous communities in the Amazon and responsibly harvesting and commercializing the first-ever plant-based oral medicine...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Death
Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021
September 27, 2021
Leading oncologists discuss importance of supportive care for cancer patients to address debilitating diarrhea resulting from cancer therapy Virtual event 1:00 PM to 2:10 PM Eastern Registration open...
From
Jaguar Health, Inc.
Via
AccessWire
Jaguar Health Receives "Complete" Letter from FDA for Last of Four Major Technical Sections for the Company's Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs
September 23, 2021
Jaguar planning for launch of Canalevia™ for CID in dogs this December Canalevia is the first and only oral plant-based prescription drug candidate for CID in dogs SAN FRANCISCO, CA / ACCESSWIRE /...
From
Jaguar Health, Inc.
Via
AccessWire
REMINDER: Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Eastern Time
September 16, 2021
Click here to register for webcast Jaguar kicks off educational awareness contest in honor of Indigenous Peoples' Day; Click here to enter SAN FRANCISCO, CA / ACCESSWIRE / September 16, 2021 / Jaguar...
From
Jaguar Health, Inc.
Via
AccessWire
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
September 15, 2021
The conditional marketing authorization pathway in Europe for crofelemer for this orphan disease is the initial focus of Napo EU under the license agreement between Napo EU and Napo Pharmaceuticals...
From
Jaguar Health, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 14, 2021
Gainers Xeris Pharmaceuticals (NASDAQ:XERS
Via
Benzinga
Jaguar Health Announces Closing of Private Placement Priced at a Premium to Market
September 14, 2021
Participating investors include Jaguar CEO and CFO, Dragon SPAC S.p.A. sponsor Josh Mailman, and plant-based pharmaceutical manufacturing pioneer Indena S.p.A. Company to host investor webcast Monday,...
From
Jaguar Health, Inc.
Via
AccessWire
Topics
Regulatory Compliance
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
